TREM2 and Alzheimer disease: TREM2 deficiency first affects CD45hi myeloid cells, where it is primarily expressed, but subsequent loss of these CD45hi cells also affects the function of CD45lo myeloid cells, decreasing their proliferation and potentially altering other AD-related phenotypes.